Literature DB >> 8193728

Circadian blood pressure variations in endocrine disorders.

C Spieker1, M Barenbrock, K H Rahn, W Zidek.   

Abstract

Circadian rhythm of blood pressure and of heart rate was studied in patients with hyperthyroidism (n = 10), pheochromocytoma (n = 8), primary hyperaldosteronism (n = 7), and in a control group of essential hypertensive patients (n = 18) and of normotensive healthy subjects (n = 11). 24-hour blood pressure was monitored non-invasively using SpaceLabs (SL 90207) with 8-min intervals in the daytime (8 a.m. to 10 p.m.) and 30-min intervals during night-time (10 p.m. to 8 a.m.). To characterize circadian blood pressure rhythm the difference between the mean blood pressure during daytime and that during night-time was calculated. In patients with hyperthyroidism the day-night difference of the systolic and diastolic blood pressure and of the heart rate was significantly reduced when compared to the normotensive control group (p < 0.05). The day-night difference of the systolic and diastolic blood pressure was significantly lower in the group with pheochromocytoma and hyperthyroidism than in the essential hypertensive controls (p < 0.05); the day-night difference of the heart rate was similar. In the patients with primary hyperaldosteronism the day-night differences of the systolic and diastolic blood pressure and of the heart rate was similar to those in essential hypertensive controls. We conclude that endocrine disorders affecting sympathetic activity like pheochromocytoma or hyperthyroidism influence the circadian blood pressure rhythm, whereas the renin-aldosterone-system has no major impact on the diurnal blood pressure variation. The results therefore support the hypothesis that circadian blood pressure variation is mainly mediated by a modulation of the sympathetic tone.

Entities:  

Mesh:

Year:  1993        PMID: 8193728     DOI: 10.3109/08037059309077524

Source DB:  PubMed          Journal:  Blood Press        ISSN: 0803-7051            Impact factor:   2.835


  7 in total

1.  Circadian blood pressure profile in patients with Cushing's syndrome before and after treatment.

Authors:  S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

2.  Cushing's syndrome: all variants, detection, and treatment.

Authors:  Susmeeta T Sharma; Lynnette K Nieman
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

3.  Diurnal blood pressure pattern and cardiac damage in hypertensive patients with primary aldosteronism.

Authors:  Qihong Wu; Mona Hong; Jianzhong Xu; Xiaofeng Tang; Limin Zhu; Pingjin Gao; Jiguang Wang
Journal:  Endocrine       Date:  2021-01-21       Impact factor: 3.633

4.  Diurnal blood pressure pattern in patients with primary aldosteronism.

Authors:  S Zacharieva; M Orbetzova; A Elenkova; A Stoynev; M Yaneva; R Schigarminova; K Kalinov; E Nachev
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

5.  Ambulatory blood pressure monitoring in secondary arterial hypertension due to adrenal diseases.

Authors:  Michele Ceruti; Luigi Petramala; Dario Cotesta; Sabrina Cerci; Valentina Serra; Chiara Caliumi; Monica Iorio; Giorgio De Toma; Antonio Ciardi; Domenico Vitolo; Claudio Letizia
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-09       Impact factor: 3.738

6.  Endocrine hypertension - Cushing's syndrome.

Authors:  Yashpal Singh; Narendra Kotwal; A S Menon
Journal:  Indian J Endocrinol Metab       Date:  2011-10

Review 7.  Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma.

Authors:  Mouna Tabebi; Peter Söderkvist; Lasse D Jensen
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.